Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2022 Volume 24 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2022 Volume 24 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

IL‑6 inhibitors effectively reverse post‑infarction cardiac injury and ischemic myocardial remodeling via the TGF‑β1/Smad3 signaling pathway

  • Authors:
    • Jiahong Wang
    • Minghong Wang
    • Xiancheng Lu
    • Yi Zhang
    • Siliang Zeng
    • Xin Pan
    • Yimeng Zhou
    • Hui Wang
    • Nannan Chen
    • Fengfeng Cai
    • Ewelina Biskup
  • View Affiliations / Copyright

    Affiliations: Department of Cardiology, Yangpu Hospital, School of Medicine, Tongji University, Shanghai 200090, P.R. China, Department of Health Management Center, Shanghai Public Health Clinical Center, Shanghai 201508, P.R. China, Department of Nutrition, Shanghai Yangpu Hospital of Traditional Chinese Medicine, Shanghai 200090, P.R. China, Department of Breast Surgery, Yangpu Hospital, School of Medicine, Tongji University, Shanghai 200090, P.R. China, Department of Rehabilitation Therapy, Shanghai Normal University Tianhua College, Shanghai 201815, P.R. China, Institute for Regenerative Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200123, P.R. China, Department of Cardiology, Yangpu Hospital, School of Medicine, Tongji University, Shanghai 200090, P.R. China, Laboratory of Tumor Molecular Biology, School of Basic Medical Sciences, Shanghai University of Medicine and Health Sciences, Shanghai 201318, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 576
    |
    Published online on: July 18, 2022
       https://doi.org/10.3892/etm.2022.11513
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Approximately one in four myocardial infarctions occur in older patients. The majority of therapeutic advances are either not appropriate or not tested in elderly patients. The main reasons for deviating from the guidelines are justified concerns regarding the effectiveness of the recommended forms of therapy, fear of adverse drug reactions and ethical concerns. Targeting interleukin 6 (IL‑6) for ventricular remodeling after cardiovascular damage is a feasible alternative to standard polypharmaceutics, but the underlying molecular mechanisms are not well understood. Continuous activation of the IL‑6‑associated cytokine receptor gp130 leads to cardiomyopathic hypertrophy. TGFβ1 is involved in forming fibrosis in various organs, and its overexpression can cause myocardial hypertrophy and fibrosis. Il‑6 has been hypothesized to be indirectly involved in cardiac remodeling via the TGFβ1/Smad signaling transduction pathway. In the present study, a rat model of acute myocardial ischemia, IL‑6 and IL‑6 receptor blockers were injected directly into the necrotic myocardium. Changes in cardiac function, myocardial infarction area, myocardial collagen, necrotic myocardial fibrosis and levels of TGFβ1, IL‑6 and MMP2/9 were quantified in myocardial tissue fibrosis by ELISA. The present study demonstrated that IL‑6 stimulated myocardial fibrosis through the TGFβ1‑Smad‑MM2/9 signaling transduction pathway. Overall, this provided a solid foundation for understanding the relationship between IL‑6 and ventricular remodeling.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Iuchi A, Harada H and Tanaka T: IL-6 blockade for myocardial infarction. Int J Cardiol. 271:19–20. 2018.PubMed/NCBI View Article : Google Scholar

2 

Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Weiss T, Eritsland J and Andersen GØ: IL-6 signalling in patients with acute ST-elevation myocardial infarction. Results Immunol. 4:8–13. 2014.PubMed/NCBI View Article : Google Scholar

3 

Gabriel AS, Martinsson A, Wretlind B and Ahnve S: IL-6 levels in acute and post myocardial infarction: Their relation to CRP levels, infarction size, left ventricular systolic function, and heart failure. Eur J Intern Med. 15:523–528. 2004.PubMed/NCBI View Article : Google Scholar

4 

Azevedo PS, Polegato BF, Minicucci MF, Paiva SA and Zornoff LA: Cardiac Remodeling: Concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq Bras Cardiol. 106:62–69. 2016.PubMed/NCBI View Article : Google Scholar

5 

Möttönen MJ, Ukkola O, Lumme J, Kesäniemi YA, Huikuri HV and Perkiömäki JS: Cardiac remodeling from middle age to senescence. Front Physiol. 8(341)2017.PubMed/NCBI View Article : Google Scholar

6 

Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L, Andersen HR, Betriu A, Savonitto S, Adamus J, et al: Facilitated PCI in patients with ST-Elevation myocardial infarction. N Engl J Med. 358:2205–2217. 2008.PubMed/NCBI View Article : Google Scholar

7 

Ohtsuka T, Hamada M, Inoue K, Ohshima K, Suzuki J, Matsunaka T, Ogimoto A, Hara Y, Shigematsu Y and Higaki J: Relation of circulating interleukin-6 to left ventricular remodeling in patients with reperfused anterior myocardial infarction: Relation of circulating interleukin-6 to left ventricular remodeling in patients with reperfused anterior myocardial infarction. Clin Cardiol. 27:417–420. 2004.PubMed/NCBI View Article : Google Scholar

8 

González A, Ravassa S, López B, Moreno MU, Beaumont J, San José G, Querejeta R, Bayés-Genís A and Díez J: Myocardial remodeling in hypertension. Hypertension. 72:549–558. 2018.PubMed/NCBI View Article : Google Scholar

9 

Williams A, Kamper SJ, Wiggers JH, O'Brien KM, Lee H, Wolfenden L, Yoong SL, Robson E, McAuley JH, Hartvigsen J and Williams CM: Musculoskeletal conditions may increase the risk of chronic disease: A systematic review and meta-analysis of cohort studies. BMC Med. 16(167)2018.PubMed/NCBI View Article : Google Scholar

10 

French BA and Kramer CM: Mechanisms of postinfarct left ventricular remodeling. Drug Discov Today Dis Mech. 4:185–196. 2007.PubMed/NCBI View Article : Google Scholar

11 

Segura AM, Frazier OH and Buja LM: Fibrosis and heart failure. Heart Fail Rev. 19:173–185. 2014.PubMed/NCBI View Article : Google Scholar

12 

Lan HY: Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. Int J Biol Sci. 7:1056–1067. 2011.PubMed/NCBI View Article : Google Scholar

13 

Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K and ten Dijke P: TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16:5353–5362. 1997.PubMed/NCBI View Article : Google Scholar

14 

Arrigo M, Jessup M, Mullens W, Reza N, Shah AM, Sliwa K and Mebazaa A: Acute heart failure. Nat Rev Dis Primers. 6(16)2020.PubMed/NCBI View Article : Google Scholar

15 

Mebazaa A, Pitsis AA, Rudiger A, Toller W, Longrois D, Ricksten SE, Bobek I, De Hert S, Wieselthaler G, Schirmer U, et al: Clinical review: Practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care. 14(201)2010.PubMed/NCBI View Article : Google Scholar

16 

Hanif K, Bid HK and Konwar R: Reinventing the ACE inhibitors: Some old and new implications of ACE inhibition. Hypertens Res. 33:11–21. 2010.PubMed/NCBI View Article : Google Scholar

17 

Rich MW, Chyun DA, Skolnick AH, Alexander KP, Forman DE, Kitzman DW, Maurer MS, McClurken JB, Resnick BM, Shen WK, et al: Knowledge Gaps in cardiovascular care of the older adult population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society. J Am Coll Cardiol. 67:2419–2140. 2016.PubMed/NCBI View Article : Google Scholar

18 

Moffat K and Mercer SW: Challenges of managing people with multimorbidity in today's healthcare systems. BMC Fam Pract. 16(129)2015.PubMed/NCBI View Article : Google Scholar

19 

Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, et al: Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 163:2345–2353. 2003.PubMed/NCBI View Article : Google Scholar

20 

Siddiqi S and Sussman MA: Cardiac hegemony of senescence. Curr Transl Geriatr Exp Gerontol Rep 2: 10.1007/s13670-013-0064-3, 2013.

21 

Sussman MA and Anversa P: Myocardial aging and senescence: Where have the stem cells gone? Annu Rev Physiol. 66:29–48. 2004.PubMed/NCBI View Article : Google Scholar

22 

Torella D, Rota M, Nurzynska D, Musso E, Monsen A, Shiraishi I, Zias E, Walsh K, Rosenzweig A, Sussman MA, et al: Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res. 94:514–524. 2004.PubMed/NCBI View Article : Google Scholar

23 

van Merode T, van de Ven K and van den Akker M: Patients with multimorbidity and their treatment burden in different daily life domains: A qualitative study in primary care in the Netherlands and Belgium. J Comorb. 8:9–15. 2018.PubMed/NCBI View Article : Google Scholar

24 

Faustino-Rocha AI, Ginja M, Ferreira R and Oliveira PA: Studying humane endpoints in a rat model of mammary carcinogenesis. Iran J Basic Med Sci. 22:643–649. 2019.PubMed/NCBI View Article : Google Scholar

25 

Mohamed AS, Hosney M, Bassiony H, Hassanein SS, Soliman AM, Fahmy SR and Gaafar K: Sodium pentobarbital dosages for exsanguination affect biochemical, molecular and histological measurements in rats. Sci Rep. 10(378)2020.PubMed/NCBI View Article : Google Scholar

26 

Wu Y, Wan Q, Shi L, Ou J, Li Y, He F, Wang H and Gao J: Siwu granules and erythropoietin synergistically ameliorated anemia in adenine-induced chronic renal failure rats. Evid Based Complement Alternat Med. 2019(5832105)2019.PubMed/NCBI View Article : Google Scholar

27 

Kobara M, Noda K, Kitamura M, Okamoto A, Shiraishi T, Toba H, Matsubara H and Nakata T: Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice. Cardiovasc Res. 87:424–430. 2010.PubMed/NCBI View Article : Google Scholar

28 

Mochizuki D, Adams A, Warner KA, Zhang Z, Pearson AT, Misawa K, McLean SA, Wolf GT and Nör JE: Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma. Oncotarget. 6:22822–22835. 2015.PubMed/NCBI View Article : Google Scholar

29 

Arora G, Morss AM, Piazza G, Ryan JW, Dinwoodey DL, Rofsky NM, Manning WJ and Chuang ML: Differences in left ventricular ejection fraction using teichholz formula and volumetric methods by cmr: Implications for patient stratification and selection of therapy. J Cardiovasc Magn Reson. 12(P202)2010.

30 

Wandt B, Bojö L, Tolagen K and Wranne B: Echocardiographic assessment of ejection fraction in left ventricular hypertrophy. Heart. 82:192–198. 1999.PubMed/NCBI View Article : Google Scholar

31 

Konstam MA, Kramer DG, Patel AR, Maron MS and Udelson JE: Left ventricular remodeling in heart failure current concepts in clinical significance and assessment. JACC Cardiovasc Imaging. 4:98–108. 2011.PubMed/NCBI View Article : Google Scholar

32 

Eltzschig HK and Collard CD: Vascular ischaemia and reperfusion injury. Br Med Bull. 70:71–86. 2004.PubMed/NCBI View Article : Google Scholar

33 

Wu N, Zhang X, Du S, Chen D and Che R: Upregulation of miR-335 ameliorates myocardial ischemia reperfusion injury via targeting hypoxia inducible factor 1-alpha subunit inhibitor. Am J Transl Res. 10:4082–4094. 2018.PubMed/NCBI

34 

Turer AT and Hill JA: Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol. 106:360–368. 2010.PubMed/NCBI View Article : Google Scholar

35 

Jones NR, Hobbs FR and Taylor CJ: Prognosis following a diagnosis of heart failure and the role of primary care: A review of the literature. BJGP Open. 1(bjgpopen17X101013)2017.PubMed/NCBI View Article : Google Scholar

36 

Price JF: Congestive heart failure in children. Pediatr Rev. 40:60–70. 2019.PubMed/NCBI View Article : Google Scholar

37 

Klaeboe LG and Edvardsen T: Echocardiographic assessment of left ventricular systolic function. J Echocardiogr. 17:10–16. 2019.PubMed/NCBI View Article : Google Scholar

38 

Malik J, Zaidi SMJ, Rana AS, Haider A and Tahir S: Post-cardiac injury syndrome: An evidence-based approach to diagnosis and treatment. Am Heart J Plus Cardiol Res Practice. 12(100068)2021.

39 

Cahill TJ and Kharbanda RK: Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Mechanisms, incidence and identification of patients at risk. World J Cardiol. 9:407–415. 2017.PubMed/NCBI View Article : Google Scholar

40 

Cao Y, Chen L, Zhang W, Liu Y, Papaconstantinou HT, Bush CR, Townsend CM Jr, Thompson EA and Ko TC: Identification of apoptotic genes mediating TGF-β/Smad3-induced cell death in intestinal epithelial cells using a genomic approach. Am J Physiol Gastrointest Liver Physiol. 292:G28–G38. 2007.PubMed/NCBI View Article : Google Scholar

41 

Walia B, Wang L, Merlin D and Sitaraman SV: TGF-beta down-regulates IL-6 signaling in intestinal epithelial cells: Critical role of SMAD-2. FASEB J. 17:2130–2132. 2003.PubMed/NCBI View Article : Google Scholar

42 

Ge Q, Moir LM, Black JL, Oliver BG and Burgess JK: TGFβ1 induces IL-6 and inhibits IL-8 release in human bronchial epithelial cells: The role of Smad2/3. J Cell Physiol. 225:846–854. 2010.PubMed/NCBI View Article : Google Scholar

43 

Ramesh S, Wildey GM and Howe PH: Transforming growth factor beta (TGFbeta)-induced apoptosis: The rise & fall of Bim. Cell Cycle. 8:11–17. 2009.PubMed/NCBI View Article : Google Scholar

44 

Su JH, Luo MY, Liang N, Gong SX, Chen W, Huang WQ, Tian Y and Wang AP: Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases. Front Pharmacol. 12(745061)2021.PubMed/NCBI View Article : Google Scholar

45 

Shinde AV and Frangogiannis NG: Fibroblasts in myocardial infarction: A role in inflammation and repair. J Mol Cell Cardiol. 70:74–82. 2014.PubMed/NCBI View Article : Google Scholar

46 

Venugopal H, Hanna A, Humeres C and Frangogiannis NG: Properties and functions of fibroblasts and myofibroblasts in myocardial infarction. Cells. 11(1386)2022.PubMed/NCBI View Article : Google Scholar

47 

Wang JH, Zhao L, Pan X, Chen NN, Chen J, Gong QL, Su F, Yan J, Zhang Y and Zhang SH: Hypoxia-stimulated cardiac fibroblast production of IL-6 promotes myocardial fibrosis via the TGF-β1 signaling pathway. Lab Invest. 96:839–852. 2016.PubMed/NCBI View Article : Google Scholar

48 

Yang L, Roh YS, Song J, Zhang B, Liu C, Loomba R and Seki E: Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice. Hepatology. 59:483–495. 2014.PubMed/NCBI View Article : Google Scholar

49 

Okina Y, Sato-Matsubara M, Matsubara T, Daikoku A, Longato L, Rombouts K, Thanh Thuy LT, Ichikawa H, Minamiyama Y, Kadota M, et al: TGF-β1-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis. J Hepatol. 73:882–895. 2020.PubMed/NCBI View Article : Google Scholar

50 

Xu F, Liu C, Zhou D and Zhang L: TGF-β/SMAD pathway and its regulation in hepatic fibrosis. J Histochem Cytochem. 64:157–167. 2016.PubMed/NCBI View Article : Google Scholar

51 

Tarantino G, Conca P, Riccio A, Tarantino M, Di Minno MN, Chianese D, Pasanisi F, Contaldo F, Scopacasa F and Capone D: Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: Is it really benign? J Transl Med. 6(72)2008.PubMed/NCBI View Article : Google Scholar

52 

Machado MV and Cortez-Pinto H: Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatol. 58:1007–1019. 2013.PubMed/NCBI View Article : Google Scholar

53 

Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM and Stockinger B: TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 24:179–189. 2006.PubMed/NCBI View Article : Google Scholar

54 

Brun P, Giron MC, Qesari M, Porzionato A, Caputi V, Zoppellaro C, Banzato S, Grillo AR, Spagnol L, De Caro R, et al: Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system. Gastroenterology. 145:1323–1333. 2013.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang J, Wang M, Lu X, Zhang Y, Zeng S, Pan X, Zhou Y, Wang H, Chen N, Cai F, Cai F, et al: IL‑6 inhibitors effectively reverse post‑infarction cardiac injury and ischemic myocardial remodeling via the TGF‑β1/Smad3 signaling pathway. Exp Ther Med 24: 576, 2022.
APA
Wang, J., Wang, M., Lu, X., Zhang, Y., Zeng, S., Pan, X. ... Biskup, E. (2022). IL‑6 inhibitors effectively reverse post‑infarction cardiac injury and ischemic myocardial remodeling via the TGF‑β1/Smad3 signaling pathway. Experimental and Therapeutic Medicine, 24, 576. https://doi.org/10.3892/etm.2022.11513
MLA
Wang, J., Wang, M., Lu, X., Zhang, Y., Zeng, S., Pan, X., Zhou, Y., Wang, H., Chen, N., Cai, F., Biskup, E."IL‑6 inhibitors effectively reverse post‑infarction cardiac injury and ischemic myocardial remodeling via the TGF‑β1/Smad3 signaling pathway". Experimental and Therapeutic Medicine 24.3 (2022): 576.
Chicago
Wang, J., Wang, M., Lu, X., Zhang, Y., Zeng, S., Pan, X., Zhou, Y., Wang, H., Chen, N., Cai, F., Biskup, E."IL‑6 inhibitors effectively reverse post‑infarction cardiac injury and ischemic myocardial remodeling via the TGF‑β1/Smad3 signaling pathway". Experimental and Therapeutic Medicine 24, no. 3 (2022): 576. https://doi.org/10.3892/etm.2022.11513
Copy and paste a formatted citation
x
Spandidos Publications style
Wang J, Wang M, Lu X, Zhang Y, Zeng S, Pan X, Zhou Y, Wang H, Chen N, Cai F, Cai F, et al: IL‑6 inhibitors effectively reverse post‑infarction cardiac injury and ischemic myocardial remodeling via the TGF‑β1/Smad3 signaling pathway. Exp Ther Med 24: 576, 2022.
APA
Wang, J., Wang, M., Lu, X., Zhang, Y., Zeng, S., Pan, X. ... Biskup, E. (2022). IL‑6 inhibitors effectively reverse post‑infarction cardiac injury and ischemic myocardial remodeling via the TGF‑β1/Smad3 signaling pathway. Experimental and Therapeutic Medicine, 24, 576. https://doi.org/10.3892/etm.2022.11513
MLA
Wang, J., Wang, M., Lu, X., Zhang, Y., Zeng, S., Pan, X., Zhou, Y., Wang, H., Chen, N., Cai, F., Biskup, E."IL‑6 inhibitors effectively reverse post‑infarction cardiac injury and ischemic myocardial remodeling via the TGF‑β1/Smad3 signaling pathway". Experimental and Therapeutic Medicine 24.3 (2022): 576.
Chicago
Wang, J., Wang, M., Lu, X., Zhang, Y., Zeng, S., Pan, X., Zhou, Y., Wang, H., Chen, N., Cai, F., Biskup, E."IL‑6 inhibitors effectively reverse post‑infarction cardiac injury and ischemic myocardial remodeling via the TGF‑β1/Smad3 signaling pathway". Experimental and Therapeutic Medicine 24, no. 3 (2022): 576. https://doi.org/10.3892/etm.2022.11513
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team